As the U.S. stock market navigates a mixed landscape of earnings reports and inflation data, major indexes like the S&P 500 and Nasdaq Composite are on track for gains, reflecting investor optimism ...

HeartBeam has submitted a 510 (k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...

HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...

SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...

Today, as millions around the world celebrate the first day of Chinese New Year, Springroll is thrilled to announce the launch of its premier online marketplace dedicated to Asian cuisines at ...

Medrio, a global leader in clinical trial technology, today announced the release of AI-enabled reporting, an innovative new capability available within Medrio CDMS/EDC. Medrio's AI-enabled reporting ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

This was corrected on 01/05/2025 at 1:03 AM. The revised post deletes Q4 and FY24 product revenue consensus ...